Comparison between Alkosign IPO and Fabino Life Sciences IPO.
Alkosign IPO is a SME Fixed Price IPO proposed to list at BSE SME while Fabino Life Sciences IPO is a SME Fixed Price proposed to list at BSE SME.
| Alkosign IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Shreni Shares Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Alkosign IPO is up to ₹11.53 Cr whereas the issue size of the Fabino Life Sciences IPO is up to ₹3.07 Cr. The final issue price of Alkosign IPO is ₹45.00 per share and of Fabino Life Sciences IPO is ₹36.00 per share.
| Alkosign IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹45.00 per share | ₹36.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 3000 shares |
| Fresh Issue Size | 25,62,000 shares | 8,52,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.53 Cr | up to ₹3.07 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 25,62,000 shares | 8,52,000 shares |
| Issue Size Total (Amount) | up to ₹11.53 Cr | up to ₹3.07 Cr |
Alkosign IPO opens on Jan 18, 2022, while Fabino Life Sciences IPO opens on Dec 31, 2021. The closing date of Alkosign IPO and Fabino Life Sciences IPO is Jan 21, 2022, and Jan 05, 2022, respectively.
| Alkosign IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 18, 2022 | Dec 31, 2021 |
| Issue Close | Jan 21, 2022 | Jan 05, 2022 |
| Basis Of Allotment (Tentative) | Jan 27, 2022 | Jan 10, 2022 |
| Initiation of Refunds (Tentative) | Jan 28, 2022 | Jan 11, 2022 |
| Credit of Share (Tentative) | Jan 28, 2022 | Jan 12, 2022 |
| Listing date (Tentative) | Feb 01, 2022 | Jan 13, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Alkosign IPO P/E ratio is , as compared to Fabino Life Sciences IPO P/E ratio of 133.
| Alkosign IPO | Fabino Life Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 99.43 | ||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 50.41 | 56.82 | ||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 133 | |||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹24.50 Cr. | ₹7.56 Cr. | ||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||
In the Alkosign IPO Retail Individual Investors (RII) are offered 12,81,000 shares while in Fabino Life Sciences IPO retail investors are offered 12,81,000 shares. Qualified Institutional Buyers (QIB) are offered in Alkosign IPO and in Fabino Life Sciences IPO.
| Alkosign IPO | Fabino Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,38,000 shares | 48,000 shares |
| QIB | ||
| NII | 12,81,000 shares | 4,26,000 shares |
| RII | 12,81,000 shares | 4,26,000 shares |
| Employee | ||
| Others | ||
| Total | 25,62,000 shares | 8,52,000 shares |
Alkosign IPO subscribed 4.76x in total, whereas Fabino Life Sciences IPO subscribed 6.93x.
| Alkosign IPO | Fabino Life Sciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.14x | 3.49x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 6.39x | 10.36x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.76x | 6.93x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
